Article info

Original research
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Authors

  • Anaïs Jiménez-Reinoso Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain PubMed articlesGoogle scholar articles
  • Néstor Tirado Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Alba Martinez-Moreno Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  • Víctor M Díaz OneChain Immunotherapeutics S.L, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Marina García-Peydró Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain PubMed articlesGoogle scholar articles
  • Oana Hangiu Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Díez-Alonso Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain PubMed articlesGoogle scholar articles
  • Ángela Albitre Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain Instituto de Investigación Sanitaria La Princesa, Madrid, Spain PubMed articlesGoogle scholar articles
  • Petronila Penela Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain Instituto de Investigación Sanitaria La Princesa, Madrid, Spain PubMed articlesGoogle scholar articles
  • Maria L Toribio Centro de Biología Molecular Severo Ochoa CSIC-UAM, Madrid, Spain PubMed articlesGoogle scholar articles
  • Pablo Menéndez Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029-RD21; RD21/0017/0030), Madrid, Spain Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Luis Álvarez-Vallina Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII) (RICORS, RD21/0017/0029-RD21; RD21/0017/0030), Madrid, Spain PubMed articlesGoogle scholar articles
  • Diego Sánchez Martínez Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Diego Sánchez Martínez; dsanchez{at}carrerasresearch.org; Dr Pablo Menéndez; pmenendez{at}carrerasresearch.org; Dr Luis Álvarez-Vallina; lav.imas12{at}h12o.es
View Full Text

Citation

Jiménez-Reinoso A, Tirado N, Martinez-Moreno A, et al
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Publication history

  • Accepted October 19, 2022
  • First published December 23, 2022.
Online issue publication 
December 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.